Bluejay Diagnostics Statistics
Want to see BJDX full AI Analyst Report?
Bluejay Diagnostics (BJDX) Stock Statistics & Valuation Metrics
Total Valuation
Bluejay Diagnostics has a market cap or net worth of $2.62M. The enterprise value is -$849.88K.
- Market Cap
- $2.62M
- Enterprise Value
- -$849.88K
Share Statistics
Bluejay Diagnostics has 1,117,013 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,117,013
- Owned by Insiders
- 8.14%
- Owned by Institutions
- 3.56%
Financial Efficiency
Bluejay Diagnostics’s return on equity (ROE) is -1.15 and return on invested capital (ROIC) is -113.98%.
- Return on Equity (ROE)
- -1.15
- Return on Assets (ROA)
- -0.96
- Return on Invested Capital (ROIC)
- -113.98%
- Return on Capital Employed (ROCE)
- -1.16
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.14M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Bluejay Diagnostics is -0.07. Bluejay Diagnostics’s PEG ratio is -0.00.
- PE Ratio
- -0.07
- PS Ratio
- 0.00
- PB Ratio
- 0.16
- Price to FCF
- -0.50
- Price to Operating Cash Flow
- -0.25
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Bluejay Diagnostics had revenue of 0 and earned -6.85M in profits. Earnings per share was -61.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -6.95M
- Pretax Income
- -6.85M
- Net Income
- -6.85M
- EBITDA
- -6.68M
- Earnings Per Share (EPS)
- -61.00
Cash Flow
In the last 12 months, operating cash flow was -5.90M and capital expenditures -335,503, giving a free cash flow of -6.24M billion.
- Operating Cash Flow
- -5.90M
- Free Cash Flow
- -6.24M
- Free Cash Flow per Share
- -12.00
Dividends & Yields
Bluejay Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -215.64%
- Earnings Yield
- -540.04%
Stock Price Statistics
- Beta
- -0.35
- 52-Week Price Change
- -90.76%
- 50-Day Moving Average
- 3.14
- 200-Day Moving Average
- 7.01
- Relative Strength Index (RSI)
- 38.78
- Average Volume (3m)
- 337.62K
Important Dates
Bluejay Diagnostics upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Apr 16, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Bluejay Diagnostics as a current ratio of 4.88, with Debt / Equity ratio of 2.01%
- Current Ratio
- 4.88
- Quick Ratio
- 4.88
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.76
- Interest Coverage Ratio
- -8287.21
Taxes
In the past 12 months, Bluejay Diagnostics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Bluejay Diagnostics EV to EBITDA ratio is 0.93, with an EV/FCF ratio of 1.06.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.93
- EV to Free Cash Flow
- 1.06
- EV to Operating Cash Flow
- 1.12
Balance Sheet
Bluejay Diagnostics has $9.60M in cash and marketable securities with $80.67K in debt, giving a net cash position of $9.52M billion.
- Cash & Marketable Securities
- $9.60M
- Total Debt
- $80.67K
- Net Cash
- $9.52M
- Net Cash Per Share
- $8.52
- Tangible Book Value Per Share
- $18.11
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Bluejay Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 93.91%
Scores
- Smart Score
- ―
- AI Score
- 44
